HK1034909A1 - Novel fatty analogues for the treatment of diabetes - Google Patents

Novel fatty analogues for the treatment of diabetes

Info

Publication number: HK1034909A1
Authority: HK; Hong Kong
Prior art keywords: sub; treatment; diabetes; novel fatty; analogues
Prior art date: 1998-05-08

Application number

HK01105684A

Other languages

English (en)

Inventor

Rolf Berge

Original Assignee

Thia Medica As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-05-08

Filing date

2001-08-14

Publication date

2001-11-09

2001-08-14 Application filed by Thia Medica As filed Critical Thia Medica As

2001-11-09 Publication of HK1034909A1 publication Critical patent/HK1034909A1/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Emergency Medicine (AREA)
Hematology (AREA)
Obesity (AREA)
Nutrition Science (AREA)
Mycology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Endocrinology (AREA)
Gastroenterology & Hepatology (AREA)
Vascular Medicine (AREA)
Child & Adolescent Psychology (AREA)
Urology & Nephrology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Saccharide Compounds (AREA)
Fats And Perfumes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)

HK01105684A 1998-05-08 2001-08-14 Novel fatty analogues for the treatment of diabetes HK1034909A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
PCT/NO1998/000143 WO1999058120A1 (en)	1998-05-08	1998-05-08	USE OF NON-β-OXIDIZABLE FATTY ACID ANALOGUES FOR TREATMENT OF SYNDROME-X CONDITIONS
PCT/NO1999/000136 WO1999058122A1 (en)	1998-05-08	1999-04-23	Novel fatty analogues for the treatment of diabetes

Publications (1)

Publication Number	Publication Date
HK1034909A1 true HK1034909A1 (en)	2001-11-09

Family

ID=19907879

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
HK01105689A HK1034911A1 (en)	1998-05-08	2001-08-14	Novel fatty acid analogues for the treatment of secondary restenosis
HK01105684A HK1034909A1 (en)	1998-05-08	2001-08-14	Novel fatty analogues for the treatment of diabetes
HK01105690A HK1034912A1 (en)	1998-05-08	2001-08-14	Novel fatty analogues for the treatment of obesity

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
HK01105689A HK1034911A1 (en)	1998-05-08	2001-08-14	Novel fatty acid analogues for the treatment of secondary restenosis

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
HK01105690A HK1034912A1 (en)	1998-05-08	2001-08-14	Novel fatty analogues for the treatment of obesity

Country Status (18)

Country	Link
US (4)	US6441036B1 (de)
EP (5)	EP1075258B1 (de)
JP (3)	JP2002514595A (de)
KR (3)	KR100701503B1 (de)
CN (3)	CN1223343C (de)
AT (5)	ATE334666T1 (de)
AU (4)	AU7240398A (de)
BR (2)	BR9910297A (de)
CA (3)	CA2331408C (de)
DE (5)	DE69909775T2 (de)
DK (3)	DK1075258T3 (de)
ES (3)	ES2207253T3 (de)
HK (3)	HK1034911A1 (de)
NO (3)	NO333143B1 (de)
NZ (3)	NZ508045A (de)
PT (2)	PT1075258E (de)
RU (3)	RU2221558C2 (de)
WO (4)	WO1999058120A1 (de)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1999058120A1 (en) *	1998-05-08	1999-11-18	Rolf Berge	USE OF NON-β-OXIDIZABLE FATTY ACID ANALOGUES FOR TREATMENT OF SYNDROME-X CONDITIONS
GB9923078D0 (en) *	1999-09-29	1999-12-01	Phytopharm Plc	Sapogenin derivatives and their use
AUPQ291499A0 (en) *	1999-09-17	1999-10-07	Women's And Children's Hospital Adelaide	Novel nitro and sulphur containing compounds
AU784588B2 (en) *	1999-09-17	2006-05-04	Peplin Biolipids Pty Ltd	Anti-inflammatory nitro- and thia- fatty acids
AU784123B2 (en) *	1999-10-13	2006-02-09	Marco A. Chacon	Therapeutic intervention to mimic the effect of caloric restriction
NO328803B1 (no) *	2000-03-03	2010-05-18	Thia Medica	Nye fettsyreanaloger
NO20003591L (no) *	2000-07-13	2002-01-14	Thia Medica As	Fettsyreanaloger for behandling av kreft
NO20006008L (no) *	2000-11-28	2002-05-29	Thia Medica As	Fettsyreanaloger for behandling av inflammatoriske og autoimmune sykdommer
DE10115740A1 (de) *	2001-03-26	2002-10-02	Ulrich Speck	Zubereitung für die Restenoseprophylaxe
IL142535A0 (en) *	2001-04-11	2002-03-10	Yeda Res & Dev	Pharmaceutical compositions for the treatment of inflammation
IL142536A0 (en) *	2001-04-11	2002-03-10	Yeda Res & Dev	Carriers for therapeutic preparations for treatment of t-cell mediated diseases
US6908632B1 (en)	2002-04-19	2005-06-21	Pharmanex, Llc	Blood glucose modulating compositions and methods
AU2003241823A1 (en) *	2002-05-28	2003-12-12	Ajinomoto Co., Inc.	Medicinal composition for inhibiting the expression of atp-citrate lyase and use thereof
EP1515978A1 (de) *	2002-06-20	2005-03-23	IC Vec Limited	Schwefelhaltige phospholipidderivate
US20080200453A1 (en)	2002-07-29	2008-08-21	Cincotta Anthony H	Methods of treating metabolic syndrome using dopamine receptor agonists
US9655865B2 (en)	2002-07-29	2017-05-23	Veroscience, Llc	Therapeutic treatment for metabolic syndrome, type 2 diabetes, obesity, or prediabetes
US20040220190A1 (en) *	2002-07-29	2004-11-04	Cincotta Anthony H.	Methods of treating metabolic syndrome using dopamine receptor agonists
US8821915B2 (en)	2002-08-09	2014-09-02	Veroscience, Llc	Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
US20040081678A1 (en) *	2002-08-09	2004-04-29	Anthony Cincotta	Therapeutic process for the treatment of obesity and associated metabolic disorders
US7045547B2 (en) *	2002-08-20	2006-05-16	University Of Delaware	Acyl-CoA dehydrogenase allenic inhibitors
KR20050033662A (ko)	2002-09-06	2005-04-12	얀센 파마슈티카 엔.브이.	헤테로사이클릭 화합물
NZ539625A (en) *	2002-09-27	2007-11-30	Martek Biosciences Corp	Improved glycemic control for Prediabetes and/or Diabetes Type II Using Docosahexaenoic Acid
KR20050071565A (ko) *	2002-10-10	2005-07-07	예다 리서치 앤드 디벨럽먼트 캄파니 리미티드	지방 알콜의 염기성 에스테르 및 이들의 항염증제 또는면역조절제로서의 용도
FR2850650B1 (fr) *	2003-01-31	2005-03-25	Genfit S A	Utilisation therapeutique d'acylglycerols et de leurs analogues azotes et sulfures
FR2850869B1 (fr) *	2003-02-12	2005-03-25	Genfit S A	Utilisations d'aminopropanediols acyles et de leurs analogues azotes et sulfures
CA2515368A1 (en)	2003-02-13	2004-08-26	Luciano Rossetti	Regulation of food intake and glucose production by modulation of long-chain fatty acyl-coa levels in the hypothalamus
JP2007522118A (ja) *	2004-01-30	2007-08-09	ペプリンバイオリピッズピーティーワイエルティーディー	治療用分子および担体分子
US20050215558A1 (en) *	2004-03-25	2005-09-29	Cincotta Anthony H	Methods of identifying responders to dopamine agonist therapy
US8137993B2 (en) *	2004-03-25	2012-03-20	Veroscience Llc	Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof
US8137994B2 (en) *	2004-03-25	2012-03-20	Veroscience Llc	Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof
CN1961213A (zh) *	2004-05-28	2007-05-09	詹森药业有限公司	新的在清醒大鼠中静脉给药和血液取样模型
DE102004034640A1 (de)	2004-07-16	2006-02-16	Institut für Molekular- und Systemmedizin	Verfahren zur systemischen Biokorrektur eines Organismus
NO324534B1 (no) *	2004-07-19	2007-11-19	Thia Medica As	Materiale fremstilt fra en kombinasjon av ikke-β-oksiderbare fettsyreanaloger og en planteolje eller fiskeolje samt anvendelser derav
KR20070046866A (ko) *	2004-07-19	2007-05-03	티아 메디카 에이에스	단백질 물질 및 비-산화성 지방산 구성요소를 포함하는조성물
WO2006041922A2 (en) *	2004-10-08	2006-04-20	Dara Biosciences, Inc.	Agents and methods for administration to the central nervous system
US7288525B2 (en) *	2004-12-28	2007-10-30	The Research Foundation Of State University Of New York	Method for lowering serum homocysteine
US20090012067A1 (en) *	2005-02-14	2009-01-08	Luciano Rossetti	Modulation of Hypothalamic Atp-Sensitive Potassium Channels
EP1888727B1 (de)	2005-05-04	2015-04-15	Pronova BioPharma Norge AS	Neue dha-derivate und ihre verwendung als medikamente
US7586003B2 (en) *	2005-07-14	2009-09-08	Zinpro Corporation	Derivatives of seleno-amino acids
NO20053519L (no) *	2005-07-18	2007-01-19	Thia Medica As	Anvendelse av forbindelser som omfatter fettsyrer
NO20055541L (no) *	2005-11-23	2007-05-24	Berge Biomed As	Use of fatty acid analogues
GB0605900D0 (en) *	2006-03-23	2006-05-03	Lipigen As	Modulators of nuclear receptors
US20080085293A1 (en) *	2006-08-22	2008-04-10	Jenchen Yang	Drug eluting stent and therapeutic methods using c-Jun N-terminal kinase inhibitor
BRPI0718420A2 (pt) *	2006-10-20	2013-11-12	Cpd Llc	Método de restabelecimento do efeito da incretina
WO2008053331A1 (en) *	2006-11-01	2008-05-08	Pronova Biopharma Norge A/S	Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (ppar).
KR101544584B1 (ko) *	2006-11-01	2015-08-13	프로노바 바이오파마 너지 에이에스	오메가-3 지질 화합물
US7964751B2 (en) *	2007-02-26	2011-06-21	Yeda Research And Development Co. Ltd.	Enantiomers of amino-phenyl-acetic acid octadec-9-(Z) enyl ester, their salts and their uses
WO2008106091A1 (en) *	2007-02-26	2008-09-04	Yeda Research And Development Co. Ltd.	Use of long-chain alcohol derivatives for the treatment of alopecia areata
CA2702577A1 (en)	2007-10-15	2009-04-23	Jbs United, Inc.	Method for increasing performance of offspring
JP5575651B2 (ja) *	2007-10-31	2014-08-20	プロノヴァバイオファーマノルゲアーエス	新規のｄｈａ誘導体およびその医薬品としての用途
US8986253B2 (en)	2008-01-25	2015-03-24	Tandem Diabetes Care, Inc.	Two chamber pumps and related methods
KR101225320B1 (ko) *	2008-04-29	2013-01-22	에프. 호프만-라 로슈 아게	카르니틴-의존성 팔미토일 트랜스퍼라제 2 억제제로서 4-트라이메틸암모니오-뷰티레이트
EP2147910A1 (de) *	2008-07-15	2010-01-27	Pronova BioPharma Norge AS	Neue Lipid-Verbindungen
US8408421B2 (en)	2008-09-16	2013-04-02	Tandem Diabetes Care, Inc.	Flow regulating stopcocks and related methods
WO2010033878A2 (en)	2008-09-19	2010-03-25	David Brown	Solute concentration measurement device and related methods
ES2726765T3 (es)	2009-05-08	2019-10-09	Basf As	Acidos grasos poliinsaturados para el tratamiento de enfermedades relacionadas con el campo de enfermedades cardiovasculares, metabólicas e inflamatorias
US9352025B2 (en)	2009-06-05	2016-05-31	Veroscience Llc	Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders
EP3284494A1 (de)	2009-07-30	2018-02-21	Tandem Diabetes Care, Inc.	Tragbares infusionspumpensystem
US20120028335A1 (en)	2010-07-28	2012-02-02	Life Technologies Corporation	Anti-viral azide-containing compounds
US9144575B2 (en)	2010-07-28	2015-09-29	Life Technologies Corporation	Anti-viral azide containing compounds
CA2816949C (en)	2010-11-05	2017-07-04	Pronova Biopharma Norge As	Methods of treatment using lipid compounds
US9180242B2 (en)	2012-05-17	2015-11-10	Tandem Diabetes Care, Inc.	Methods and devices for multiple fluid transfer
GB201301626D0 (en) *	2013-01-30	2013-03-13	Dignity Sciences Ltd	Composition comprising 15-OHEPA and methods of using the same
JP6537980B2 (ja)	2013-02-28	2019-07-03	プロノヴァ・バイオファーマ・ノルゲ・アーエスＰｒｏｎｏｖａＢｉｏＰｈａｒｍａＮｏｒｇｅＡＳ	脂質化合物、トリグリセリドおよび界面活性剤を含む組成物、ならびにその使用方法
WO2014140934A2 (en)	2013-03-11	2014-09-18	Life Science Nutrition As	Natural lipids containing non-oxidizable fatty acids
AU2014228387B2 (en)	2013-03-11	2016-09-01	Sciadonics, Inc.	Lipid compositions containing bioactive fatty acids
US9173998B2 (en)	2013-03-14	2015-11-03	Tandem Diabetes Care, Inc.	System and method for detecting occlusions in an infusion pump
RU2522224C1 (ru) *	2013-08-06	2014-07-10	Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Уральская государственная академия ветеринарной медицины"	Способ лечения острого гепатоза у кошек
ES2787223T3 (es)	2014-11-07	2020-10-15	Univ Minnesota	Sales y composiciones útiles para tratar enfermedades
US20180104201A1 (en)	2015-04-28	2018-04-19	Pronova Biopharma Norge As	Use of structurally enhanced fatty acids containing sulphur for preventing and or treating non alcoholic steatohepatitis
US10492141B2 (en)	2015-11-17	2019-11-26	Tandem Diabetes Care, Inc.	Methods for reduction of battery usage in ambulatory infusion pumps
KR102701244B1 (ko) *	2017-10-23	2024-09-02	에피트래커, 인코포레이티드	지방산 유사체 및 대사 증후군 관련 병태 치료에서의 그의 용도
SG11202005007VA (en)	2017-12-06	2020-06-29	Basf As	Fatty acid derivatives for treating non-alcoholic steatohepatitis
CA3099482A1 (en)	2018-05-23	2019-11-28	Epitracker, Inc.	Compositions and methods for diagnosis and treatment of conditions related to the quality of aging and longevity
JP7404382B2 (ja) *	2019-03-04	2023-12-25	エピトラッカーインコーポレイテッド	脂肪酸アナログ、ならびに認知機能障害、行動症状および慢性疼痛の処置におけるそれらの使用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS59175425A (ja) *	1983-03-25	1984-10-04	Otsuka Pharmaceut Co Ltd	脳卒中予防剤
GB8813012D0 (en) *	1988-06-02	1988-07-06	Norsk Hydro As	Non-b-oxidizable fatty acid analogues to reduce concentration of cholesterol & triglycerides in blood of mammals
US6063581A (en) *	1992-01-22	2000-05-16	Axis-Shield Asa	Immunoassay for homocysteine
AU6277396A (en) *	1995-06-07	1996-12-30	Neorx Corporation	Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
NO952796D0 (no) *	1995-07-14	1995-07-14	Rolf Berge	Fettsyre analoger med ikkeoksyderbart B-sete, fremstilling og anvendelse i krapeutiske preparater
ATE221324T1 (de) *	1996-11-20	2002-08-15	Nutricia Nv	Fette enthaltende ernährungszusammensetzung zur behandlung des stoffwechselssyndroms
WO1999058120A1 (en) *	1998-05-08	1999-11-18	Rolf Berge	USE OF NON-β-OXIDIZABLE FATTY ACID ANALOGUES FOR TREATMENT OF SYNDROME-X CONDITIONS

1998
- 1998-05-08 WO PCT/NO1998/000143 patent/WO1999058120A1/en active Application Filing
- 1998-05-08 AU AU72403/98A patent/AU7240398A/en not_active Abandoned
1999
- 1999-04-23 DK DK99933292T patent/DK1075258T3/da active
- 1999-04-23 CN CNB998059684A patent/CN1223343C/zh not_active Expired - Fee Related
- 1999-04-23 KR KR1020007012282A patent/KR100701503B1/ko not_active IP Right Cessation
- 1999-04-23 US US09/700,061 patent/US6441036B1/en not_active Expired - Lifetime
- 1999-04-23 DK DK99933293T patent/DK1075259T3/da active
- 1999-04-23 AT AT02024388T patent/ATE334666T1/de not_active IP Right Cessation
- 1999-04-23 DE DE69909775T patent/DE69909775T2/de not_active Expired - Lifetime
- 1999-04-23 NZ NZ508045A patent/NZ508045A/en not_active IP Right Cessation
- 1999-04-23 JP JP2000547973A patent/JP2002514595A/ja active Pending
- 1999-04-23 AU AU49366/99A patent/AU762792B2/en not_active Ceased
- 1999-04-23 AT AT99933293T patent/ATE245416T1/de not_active IP Right Cessation
- 1999-04-23 EP EP99933292A patent/EP1075258B1/de not_active Expired - Lifetime
- 1999-04-23 BR BR9910297-8A patent/BR9910297A/pt not_active Application Discontinuation
- 1999-04-23 PT PT99933292T patent/PT1075258E/pt unknown
- 1999-04-23 EP EP02024616A patent/EP1285652B1/de not_active Expired - Lifetime
- 1999-04-23 CA CA002331408A patent/CA2331408C/en not_active Expired - Fee Related
- 1999-04-23 PT PT99933293T patent/PT1075259E/pt unknown
- 1999-04-23 KR KR1020007012281A patent/KR100701502B1/ko not_active IP Right Cessation
- 1999-04-23 RU RU2000131221/14A patent/RU2221558C2/ru not_active IP Right Cessation
- 1999-04-23 NZ NZ508047A patent/NZ508047A/en not_active IP Right Cessation
- 1999-04-23 DE DE69932864T patent/DE69932864D1/de not_active Expired - Lifetime
- 1999-04-23 BR BR9910296-0A patent/BR9910296A/pt not_active IP Right Cessation
- 1999-04-23 DE DE69932645T patent/DE69932645D1/de not_active Expired - Lifetime
- 1999-04-23 AT AT02024616T patent/ATE336239T1/de not_active IP Right Cessation
- 1999-04-23 AU AU49367/99A patent/AU762790B2/en not_active Ceased
- 1999-04-23 AT AT99933292T patent/ATE247464T1/de not_active IP Right Cessation
- 1999-04-23 US US09/700,062 patent/US6365628B1/en not_active Expired - Lifetime
- 1999-04-23 DE DE69910559T patent/DE69910559T2/de not_active Expired - Lifetime
- 1999-04-23 EP EP99933293A patent/EP1075259B1/de not_active Expired - Lifetime
- 1999-04-23 ES ES99933292T patent/ES2207253T3/es not_active Expired - Lifetime
- 1999-04-23 EP EP02024388A patent/EP1284139B1/de not_active Expired - Lifetime
- 1999-04-23 WO PCT/NO1999/000135 patent/WO1999058121A1/en active IP Right Grant
- 1999-04-23 JP JP2000547972A patent/JP5057003B2/ja not_active Expired - Fee Related
- 1999-04-23 RU RU2000131222/15A patent/RU2219920C2/ru not_active IP Right Cessation
- 1999-04-23 CN CNB998059668A patent/CN1245157C/zh not_active Expired - Fee Related
- 1999-04-23 CA CA002331395A patent/CA2331395C/en not_active Expired - Fee Related
- 1999-04-23 ES ES99933293T patent/ES2204142T3/es not_active Expired - Lifetime
- 1999-04-23 WO PCT/NO1999/000136 patent/WO1999058122A1/en active IP Right Grant
- 1999-05-07 AT AT99940723T patent/ATE306916T1/de not_active IP Right Cessation
- 1999-05-07 NZ NZ508046A patent/NZ508046A/en not_active IP Right Cessation
- 1999-05-07 AU AU54517/99A patent/AU761355B2/en not_active Ceased
- 1999-05-07 ES ES99940723T patent/ES2251218T3/es not_active Expired - Lifetime
- 1999-05-07 DE DE69927805T patent/DE69927805T2/de not_active Expired - Fee Related
- 1999-05-07 RU RU2000131220/15A patent/RU2223095C2/ru not_active IP Right Cessation
- 1999-05-07 CA CA002331393A patent/CA2331393C/en not_active Expired - Fee Related
- 1999-05-07 WO PCT/NO1999/000149 patent/WO1999058123A2/en active IP Right Grant
- 1999-05-07 EP EP99940723A patent/EP1075260B1/de not_active Expired - Lifetime
- 1999-05-07 KR KR1020007012283A patent/KR100822077B1/ko not_active IP Right Cessation
- 1999-05-07 DK DK99940723T patent/DK1075260T3/da active
- 1999-05-07 CN CNB998059676A patent/CN1244323C/zh not_active Expired - Fee Related
- 1999-05-07 US US09/674,982 patent/US6417232B1/en not_active Expired - Lifetime
- 1999-05-07 JP JP2000547974A patent/JP4465672B2/ja not_active Expired - Fee Related
2000
- 2000-10-30 NO NO20005462A patent/NO333143B1/no not_active IP Right Cessation
- 2000-10-30 NO NO20005461A patent/NO20005461L/no not_active Application Discontinuation
- 2000-10-30 NO NO20005463A patent/NO20005463L/no not_active Application Discontinuation
2001
- 2001-08-14 HK HK01105689A patent/HK1034911A1/xx not_active IP Right Cessation
- 2001-08-14 HK HK01105684A patent/HK1034909A1/xx not_active IP Right Cessation
- 2001-08-14 HK HK01105690A patent/HK1034912A1/xx not_active IP Right Cessation
2002
- 2002-05-17 US US10/151,203 patent/US7026356B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
NO20005462L (no)	2001-01-08
CA2331408A1 (en)	1999-11-18
DE69909775T2 (de)	2004-06-03
US6365628B1 (en)	2002-04-02
CA2331393C (en)	2009-08-11
CN1223343C (zh)	2005-10-19
BR9910297A (pt)	2002-01-02
ES2207253T3 (es)	2004-05-16
CN1244323C (zh)	2006-03-08
AU4936799A (en)	1999-11-29
KR20010043314A (ko)	2001-05-25
WO1999058123A2 (en)	1999-11-18
EP1075260A2 (de)	2001-02-14
CA2331395A1 (en)	1999-11-18
CA2331393A1 (en)	1999-11-18
EP1075260B1 (de)	2005-10-19
HK1034912A1 (en)	2001-11-09
EP1284139A1 (de)	2003-02-19
NO20005461D0 (no)	2000-10-30
AU5451799A (en)	1999-11-29
EP1075258A1 (de)	2001-02-14
PT1075258E (pt)	2004-01-30
WO1999058123A3 (en)	2000-03-09
AU761355B2 (en)	2003-06-05
JP2002514596A (ja)	2002-05-21
DE69932864D1 (de)	2006-09-28
JP5057003B2 (ja)	2012-10-24
KR20010043316A (ko)	2001-05-25
DE69932645D1 (de)	2006-09-14
ATE306916T1 (de)	2005-11-15
BR9910296A (pt)	2002-01-15
AU762792B2 (en)	2003-07-03
DE69927805T2 (de)	2006-07-06
WO1999058121A1 (en)	1999-11-18
CN1300211A (zh)	2001-06-20
DE69909775D1 (de)	2003-08-28
CA2331408C (en)	2008-10-21
PT1075259E (pt)	2003-12-31
EP1075258B1 (de)	2003-08-20
KR20010043315A (ko)	2001-05-25
AU7240398A (en)	1999-11-29
DK1075259T3 (da)	2003-11-03
US20020198259A1 (en)	2002-12-26
NO20005461L (no)	2001-01-08
NO20005463D0 (no)	2000-10-30
KR100822077B1 (ko)	2008-04-14
NZ508046A (en)	2003-08-29
NO20005462D0 (no)	2000-10-30
US7026356B2 (en)	2006-04-11
NO333143B1 (no)	2013-03-18
WO1999058122A1 (en)	1999-11-18
ATE247464T1 (de)	2003-09-15
JP2002514595A (ja)	2002-05-21
CA2331395C (en)	2008-10-14
EP1075259A1 (de)	2001-02-14
ES2204142T3 (es)	2004-04-16
NZ508045A (en)	2003-08-29
DE69927805D1 (de)	2006-03-02
CN1302204A (zh)	2001-07-04
RU2219920C2 (ru)	2003-12-27
NO20005463L (no)	2001-01-08
HK1034911A1 (en)	2001-11-09
EP1284139B1 (de)	2006-08-02
WO1999058120A1 (en)	1999-11-18
DK1075260T3 (da)	2006-02-06
US6417232B1 (en)	2002-07-09
ATE245416T1 (de)	2003-08-15
ES2251218T3 (es)	2006-04-16
KR100701502B1 (ko)	2007-04-02
JP4465672B2 (ja)	2010-05-19
RU2221558C2 (ru)	2004-01-20
AU762790B2 (en)	2003-07-03
RU2223095C2 (ru)	2004-02-10
ATE334666T1 (de)	2006-08-15
EP1285652A1 (de)	2003-02-26
DK1075258T3 (da)	2003-12-01
DE69910559D1 (de)	2003-09-25
CN1300212A (zh)	2001-06-20
NZ508047A (en)	2003-05-30
KR100701503B1 (ko)	2007-04-02
EP1285652B1 (de)	2006-08-16
US6441036B1 (en)	2002-08-27
ATE336239T1 (de)	2006-09-15
EP1075259B1 (de)	2003-07-23
CN1245157C (zh)	2006-03-15
AU4936699A (en)	1999-11-29
JP2002514594A (ja)	2002-05-21
DE69910559T2 (de)	2004-06-17

Publication	Publication Date	Title
HK1034909A1 (en)	2001-11-09	Novel fatty analogues for the treatment of diabetes
AU2019502A (en)	2002-06-18	Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
BG103485A (en)	2000-01-31	Ketobanzamides as calpain inhibitors
CA2288445A1 (en)	2000-05-05	5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives
SI1501507T1 (sl)	2008-12-31	Tetrahidropiranil ciklopentil tetrahidropiridopiridin modulatorji s kemokinsko receptorsko aktivnostjo
NZ279397A (en)	1997-08-22	Mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives and pharmaceutucal compositions
EP1077218A3 (de)	2001-12-19	RGD-Sequenzen enthaltende peptido-mimetische Verbindungen als Integrin Inhibitioren
MXPA04002282A (es)	2005-03-07	Nuevos compuestos y preparaciones como inhibidores de la catepsina.
IL126235A0 (en)	1999-05-09	Compounds with growth hormone releasing properties
HK1068332A1 (en)	2005-04-29	Pyrane derivatives as both ace-and nep-inhibitors
AU1100897A (en)	1997-07-03	Stabilized antisun compositions
WO2002008161A3 (en)	2002-06-13	Polymerization inhibitor for vinyl-containing materials
PL343546A1 (en)	2001-08-27	Processes for preparing intermediates
GR3029590T3 (en)	1999-06-30	Crystalline, polymorphic form of (s,s,s)-n-(1- 2-carboxy-3-(n?2 -mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine
ZA983231B (en)	1999-10-18	Substituted benzyloxyimino compounds.
HK1048814A1 (en)	2003-04-17	Process for the preparation of 2-cyanopyridines 2-.
WO2004041830A3 (en)	2005-05-26	An improved process for the preparation of biotin

Legal Events

Date	Code	Title	Description
2004-12-15	PF	Patent in force
2011-12-09	PC	Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)	Effective date: 20110423